Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 4
2016 1
2017 2
2018 3
2019 5
2020 1
2021 4
2022 9
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen.
Dobaño C, Jiménez A, Rubio R, Alonso S, Ramírez-Morros A, Vidal M, Vidal-Alaball J, Ruiz-Comellas A, García-Basteiro AL, Izquierdo L, Aguilar R, Moncunill G. Dobaño C, et al. Among authors: ramirez morros a. Transl Res. 2022 Feb;240:26-32. doi: 10.1016/j.trsl.2021.10.004. Epub 2021 Oct 25. Transl Res. 2022. PMID: 34710636 Free PMC article.
Sustained seropositivity up to 20.5 months after COVID-19.
Dobaño C, Ramírez-Morros A, Alonso S, Rubio R, Ruiz-Olalla G, Vidal-Alaball J, Macià D, Catalina QM, Vidal M, Casanovas AF, Prados de la Torre E, Barrios D, Jiménez A, Zanoncello J, Melero NR, Carolis C, Izquierdo L, Aguilar R, Moncunill G, Ruiz-Comellas A. Dobaño C, et al. Among authors: ramirez morros a. BMC Med. 2022 Oct 13;20(1):379. doi: 10.1186/s12916-022-02570-3. BMC Med. 2022. PMID: 36224590 Free PMC article.
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageourgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders BJA; CoV-Early study group; COnV-ert study group. Millat-Martinez P, et al. Among authors: ramirez morros a. Nat Commun. 2022 May 11;13(1):2583. doi: 10.1038/s41467-022-29911-3. Nat Commun. 2022. PMID: 35546145 Free PMC article.
Role of the Scavenger Receptor CD36 in Accelerated Diabetic Atherosclerosis.
Navas-Madroñal M, Castelblanco E, Camacho M, Consegal M, Ramirez-Morros A, Sarrias MR, Perez P, Alonso N, Galán M, Mauricio D. Navas-Madroñal M, et al. Among authors: ramirez morros a. Int J Mol Sci. 2020 Oct 5;21(19):7360. doi: 10.3390/ijms21197360. Int J Mol Sci. 2020. PMID: 33028031 Free PMC article.
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.
Alemany A, Millat-Martinez P, Corbacho-Monné M, Malchair P, Ouchi D, Ruiz-Comellas A, Ramírez-Morros A, Rodríguez Codina J, Amado Simon R, Videla S, Costes G, Capdevila-Jáuregui M, Torrano-Soler P, San José A, Bonet Papell G, Puig J, Otero A, Ruibal Suarez JC, Zarauza Pellejero A, Llopis Roca F, Rodriguez Cortez O, Garcia Garcia V, Vidal-Alaball J, Millan A, Contreras E, Grifols JR, Ancochea À, Galvan-Femenia I, Piccolo Ferreira F, Bonet M, Cantoni J, Prat N, Ara J, Forcada Arcarons A, Farré M, Pradenas E, Blanco J, Àngel Rodriguez-Arias M, Fernández Rivas G, Marks M, Bassat Q, Blanco I, Baro B, Clotet B, Mitjà O; CONV-ERT Group. Alemany A, et al. Among authors: ramirez morros a. Lancet Respir Med. 2022 Mar;10(3):278-288. doi: 10.1016/S2213-2600(21)00545-2. Epub 2022 Feb 9. Lancet Respir Med. 2022. PMID: 35150610 Free PMC article. Clinical Trial.
Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and naïve primary health care workers upon COVID-19 vaccination.
Dobaño C, Ramírez-Morros A, Alonso S, Ruiz-Olalla G, Rubio R, Vidal M, Prados de la Torre E, Jairoce C, Mitchell RA, Barrios D, Jiménez A, Rodrigo Melero N, Carolis C, Izquierdo L, Zanoncello J, Aguilar R, Vidal-Alaball J, Moncunill G, Ruiz-Comellas A. Dobaño C, et al. Among authors: ramirez morros a. Immunology. 2022 Dec;167(4):528-543. doi: 10.1111/imm.13551. Epub 2022 Sep 6. Immunology. 2022. PMID: 36065677
Motivation for Vaccination against COVID-19 in Persons Aged between 18 and 60 Years at a Population-Based Vaccination Site in Manresa (Spain).
Sauch Valmaña G, Fuster-Casanovas A, Ramírez-Morros A, Rodoreda Pallàs B, Vidal-Alaball J, Ruiz-Comellas A, Miró Catalina Q. Sauch Valmaña G, et al. Among authors: ramirez morros a. Vaccines (Basel). 2022 Apr 12;10(4):597. doi: 10.3390/vaccines10040597. Vaccines (Basel). 2022. PMID: 35455345 Free PMC article.
28 results